BioLineRx Ltd. (TLV:BLRX)
1.600
+0.100 (6.67%)
At close: Jan 9, 2026
BioLineRx Revenue
BioLineRx had revenue of $427.00K USD in the quarter ending September 30, 2025, a decrease of -91.36%. This brings the company's revenue in the last twelve months to $12.74M, down -42.09% year-over-year. In the year 2024, BioLineRx had annual revenue of $28.94M with 502.92% growth.
Revenue (ttm)
$12.74M
Revenue Growth
-42.09%
P/S Ratio
0.99
Revenue / Employee
$454.82K
Employees
28
Market Cap
41.77M ILS
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 28.94M | 24.14M | 502.92% |
| Dec 31, 2023 | 4.80M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.55B |
| Danel (Adir Yeoshua) | 2.87B |
| Novolog (Pharm-Up 1966) | 1.97B |
| Ilex Medical | 917.10M |
| Kamada | 578.74M |
| SofWave Medical | 255.13M |
| BrainsWay | 162.56M |
| Bait Bakfar | 107.78M |
BioLineRx News
- 6 weeks ago - BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - BioLineRx (BLRX) Surpasses Q3 EPS Estimates Despite Revenue Shortfall - GuruFocus
- 6 weeks ago - BioLineRx (BLRX) Q3 Revenue Declines Amid New Joint Venture - GuruFocus
- 6 weeks ago - BioLineRx GAAP EPS of $0.00 beats by $0.54, revenue of $0.43M misses by $0.24M - Seeking Alpha
- 6 weeks ago - BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 6 weeks ago - Earnings Scheduled For November 24, 2025 - Benzinga
- 7 weeks ago - BioLine Rx's Earnings: A Preview - Benzinga
- 7 weeks ago - BioLineRx Q3 2025 Earnings Preview - Seeking Alpha